DPI-3290 was discovered by scientists at Burroughs Wellcome and licensed to Delta Pharmaceutical US Patent 5552404 - Opioid compounds and methods for using same and is a drug that is used in scientific research. It is a potent analgesic drug, which produces little respiratory depression.
DPI-3290 acts as an agonist at both μ- and δ-opioid receptor, with an IC50 of 6.2nM at μ and 1.0nM at δ.
See also AZD2327 BW373U86 DPI-221 DPI-287
References